Abstract
AADC (Aromatic L-amino acid decarboxylase) is a lyase enzyme. It is a well known potential drug target for neurological disorders. Selective AADC inhibitors are used in the treatment of neurological disorders such as Parkinson's. The aim of this work is to develop specific inhibitors, which may overcome the side effects that the existing inhibitors suffer from. In the light of these facts, AADC enzyme has been modelled and ligands have been generated from AADC enzyme with its known binding site using LUDI. Also, binding affinity of the ligand towards the enzyme has been enhanced. The number of ligands was selected based on the intermolecular h-bonds with receptor, polar surface area, molecular volume, Lipinski's rule of five and docking studies. Finally, pharmacophoric features present in the selected ligands were predicted.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: International Journal of Medical Engineering and Informatics
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
